SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-039951
Filing Date
2020-08-13
Accepted
2020-08-13 14:57:33
Documents
69
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cmpx-10q_20200630.htm 10-Q 2183077
2 EX-31.1 cmpx-ex311_11.htm EX-31.1 18532
3 EX-31.2 cmpx-ex312_10.htm EX-31.2 18606
4 EX-32.1 cmpx-ex321_8.htm EX-32.1 9180
5 EX-32.2 cmpx-ex322_9.htm EX-32.2 9086
  Complete submission text file 0001564590-20-039951.txt   6546690

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cmpx-20200630.xml EX-101.INS 1214000
7 XBRL TAXONOMY EXTENSION SCHEMA cmpx-20200630.xsd EX-101.SCH 47352
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cmpx-20200630_cal.xml EX-101.CAL 38602
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cmpx-20200630_def.xml EX-101.DEF 148438
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmpx-20200630_lab.xml EX-101.LAB 365238
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmpx-20200630_pre.xml EX-101.PRE 287642
Mailing Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142
Business Address 245 FIRST STREET, 3RD FLOOR CAMBRIDGE MA 02142 617-500-8099
Compass Therapeutics, Inc. (Filer) CIK: 0001738021 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55939 | Film No.: 201098895
SIC: 2836 Biological Products, (No Diagnostic Substances)